1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Biopharmaceutical Logistics Industry Insights

4.1. Industry Value Chain Analysis

4.1.1.   Vendor Matrix

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company market share analysis,2018

4.6. Porter’s Five forces analysis

4.6.1.   Bargaining Power of Suppliers

4.6.2.   Bargaining Power of Buyers

4.6.3.   Threat of New Entrants

4.6.4.   Threat of Substitutes

4.6.5.   Intensity of Rivalry

4.7. PESTEL Analysis

4.8. Strategic Outlook

5.    Global Biopharmaceutical Logistics Market Overview

5.1. Market Size & Forecast 2015-2025

5.1.1.   By Value (USD)

5.2. Market Share & Forecast

5.2.1.   By Logistics Type

5.2.1.1.       Cold Chain Logistics

5.2.1.2.       Non-cold Chain Logistics

5.2.2.   By Product Type

5.2.2.1.       Generic Drugs

5.2.2.2.       Branded Drugs

5.2.3.   By Mode of Transportation

5.2.3.1.       Air Shipping

5.2.3.2.       Sea Shipping

5.2.3.3.       Road Shipping

5.2.3.4.       Rail Shipping

5.2.4.   By Retail Format

5.2.4.1.       Specialty Stores

5.2.4.2.       Hyper Markets

5.2.4.3.       Departmental Stores

5.2.4.4.       Other Retailers

5.2.5.   By Region

5.2.5.1.       North America

5.2.5.2.       Europe

5.2.5.3.       Asia Pacific

5.2.5.4.       Latin America

5.2.5.5.       Middle East & Africa

6.    North America Biopharmaceutical Logistics Market

6.1. Key Regional Trends

6.2. Market estimates & forecast

6.2.1.   By Logistic Type

6.2.2.   By Product Type

6.2.3.   By Mode of Transportation

6.2.4.   By Retail Format

6.2.5.   By Country

6.2.5.1.       U.S

6.2.5.2.       Canada

7.    Europe Biopharmaceutical Logistics Market

7.1. Key Regional Trends

7.2. Market estimates & forecast

7.2.1.   By Logistic Type

7.2.2.   By Product Type

7.2.3.   By Mode of Transportation

7.2.4.   By Retail Format

7.2.5.   By Country

7.2.5.1.       Germany

7.2.5.2.       U.K

7.2.5.3.       France

7.2.5.4.       Italy

7.2.5.5.       Rest of Europe

8.    Asia Pacific Biopharmaceutical Logistics Market

8.1. Key Regional Trends

8.2. Market estimates & forecast

8.2.1.   By Logistic Type

8.2.2.   By Product Type

8.2.3.   By Mode of Transportation

8.2.4.   By Retail Format

8.2.5.   By Country

8.2.5.1.       China

8.2.5.2.       India

8.2.5.3.       Japan

8.2.5.4.       Rest of APAC

9.    Latin America Biopharmaceutical Logistics Market

9.1. Key Regional Trends

9.2. Market estimates & forecast

9.2.1.   By Logistic Type

9.2.2.   By Product Type

9.2.3.   By Mode of Transportation

9.2.4.   By Retail Format

9.2.5.   By Country

9.2.5.1.       Brazil

9.2.5.2.       Argentina

9.2.5.3.       Rest of Latin America

10. Middle East & Africa Biopharmaceutical Logistics Market

10.1.             Key Regional Trends

10.2.             Market estimates & forecast

10.2.1. By Logistic Type

10.2.2. By Product Type

10.2.3. By Mode of Transportation

10.2.4. By Retail Format

10.2.5. By Country

10.2.5.1.    Saudi Arabia

10.2.5.2.    UAE

10.2.5.3.    South Africa

10.2.5.4.    Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

11.1.             Deutsche Post DHL

11.2.             Kuehne + Nagel

11.3.             DB Schenker FedEx

11.4.             AmerisourceBergen

11.5.             UPS (Marken)

11.6.             XPO Logistics

11.7.             Panalpina

11.8.             VersaCold

11.9.             Agility

11.10.          DSV

11.11.          Other Prominent Players

12. Strategic Recommendation

 

*Financial Details Not Be Captured in Case of Unlisted Companies

 

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable